Heat Shock Protein 27 Expression Levels are associated with the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib
Explore this paper's citation graph
- Type
- article
- Published
- 2022-01-01
- Cited by
- 0
- References
- 0
- Access
- Open access
- OpenAlex
- https://openalex.org/W4285206599
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:249027255
Keywords
Sorafenib, Hepatocellular carcinoma, Medicine, Cancer research, Liver cancer
References
No references recorded for this paper.
Cited by
No citing papers recorded for this paper.
Related papers
- Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma.
- Significance of PIVKA-II in sorafenib therapy for advanced hepatocellular carcinoma
- High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma
- Treatment options after sorafenib failure in patients with hepatocellular carcinoma
- Data from High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma
- Sorafenib in hepatocellular carcinoma.
- Complete Regression of Recurrent Advanced Hepatocellular Carcinoma After Liver Transplantation in Response to Sorafenib Treatment: A Case Report.
- Supplementary Methods from SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model